While Akili's EPS outperformed expectations, the miss on sales forecasts could temper investor enthusiasm. However, the dramatic year-over-year sales growth indicates significant business expansion, which might offset concerns about the sales miss in the short term. The mixed results make the short-term stock price direction uncertain, hence a neutral score.